Literature DB >> 6304182

1,300 mg of aspirin daily does not cause positive fecal hemoccult tests.

R G Norfleet.   

Abstract

Americans 50 years of age and older are advised to test their stools for occult blood to detect colorectal neoplasms. Many will be taking 1,300 mg of aspirin daily because of cerebrovascular disease or smaller amounts for cardiovascular disease. To determine if 1,300 mg of aspirin causes positive hemoccult II tests, 27 healthy volunteers ate a red meat-free, high-fiber diet. Their stools were negative for occult blood during a 3-day control period and remained negative while they took 1,300 mg aspirin daily for an additional 7 days. This indicates that 1,300 mg aspirin daily for 1 week does not cause positive hemoccult II testing. Those taking this dose of aspirin probably need not interrupt therapy to perform hemoccult II testing.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304182     DOI: 10.1097/00004836-198304000-00006

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  Influence of non-steroidal anti-inflammatory drugs in faecal occult blood tests.

Authors:  Y Niv
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-15

Review 2.  Are medication restrictions before FOBT necessary?: practical advice based on a systematic review of the literature.

Authors:  Gerald Konrad; Alan Katz
Journal:  Can Fam Physician       Date:  2012-09       Impact factor: 3.275

Review 3.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs.

Authors:  Mandeep S Sawhney; Heather McDougall; Douglas B Nelson; John H Bond
Journal:  Dig Dis Sci       Date:  2010-03-03       Impact factor: 3.199

5.  Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.

Authors:  R F Logan; J Little; P G Hawtin; J D Hardcastle
Journal:  BMJ       Date:  1993-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.